Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elvira Trueba"'
Autor:
Yolanda Mendoza, Alejandro Nájera, Rosa Maria Arana, Elvira Trueba, Manuel López-Hernández, José R. Borbolla
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 10:19-21
19 To the editor: Chronic myelogenous leukemia (CML) is only curable with allogeneic stem cell transplant (AlloSCT) (1–5). Allo-SCT is usually limited to patients less than 50–55 years of age, and because only a small number of patients have a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4599e58ec85ac4a742ca52039b0e88c6
https://doi.org/10.1089/152581601750098156
https://doi.org/10.1089/152581601750098156
Autor:
José R. Borbolla, Manuel López-Hernández, Rosa María Romero Jiménez, Mauricio González-Avante, Elvira Trueba, Martha Alvarado, José DeDiego
Publikováno v:
Chemotherapy. 47(5)
Background: High-intensity regimes of chemotherapy have led to longer and more severe episodes of neutropenia with a resulting increase in morbidity and mortality due to infections. Which empiric antibiotic regimen to use in these cases is still unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4128eb1e1fb69e9e8bea5e312617102
https://pubmed.ncbi.nlm.nih.gov/11561142
https://pubmed.ncbi.nlm.nih.gov/11561142
Autor:
José DeDiego, Martha Alvarado, José R. Borbolla, Rosa María Romero Jiménez, Mauricio González-Avante, Elvira Trueba, Manuel López-Hernández
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 9:415-416
415 To the editor: The infusion of donor mononuclear cells (MNC) for the treatment of relapse after stem cell transplant in leukemias is already considered as standard practical procedure (1–5). Some cases of failure using this regime have been rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae1269a7bbc4aeaae12af8a061938929
https://doi.org/10.1089/152581600419062
https://doi.org/10.1089/152581600419062
Autor:
Elvira Trueba, Martha Alvarado, MA López, J. R. Borbolla, M González, L Guzman, I. Anaya, José DeDiego
Publikováno v:
Bone Marrow Transplantation. 20:707-708
A 15-year-old female with pre-pre B ALL in third relapse was treated with administration of eight blood bank leukocyte concentrates per day for 5 days. The total number of mononuclear cells per kilogram of weight was 4.89 x 10(8). On the fifth day of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e772e0a90b3e9ac8e5c5f64cf88df493
https://doi.org/10.1038/sj.bmt.1700953
https://doi.org/10.1038/sj.bmt.1700953
Autor:
Yara E. Tovar, Manuel López-Hernández, Cecilia Ramirez-Assad, Gerardo Villareal, Rosa E. De Leon, Enrique Baez, Roberto Hernandez, Martha Alvarado, Jose Luis Cedillo, Jose E. DeDiego-FloresChapa, Maria I. Leon, Severiano Baltazar, Marcos E. Garza, Jason A. Penniecook, Elvira Trueba, Mauricio González-Avante, Jose R. Borbolla Escoboza
Publikováno v:
Blood. 104:5015-5015
Introduction: Autologus Stem Cell Transplant (ASCT) has found it’s place in the therapy of some common neoplastic diseases such as lymphoma, Hodgkin’s disease and multiple myeloma, and is still under research in a many other malignant and non-mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2570272e2797aa42244d2f4a39084b9
https://doi.org/10.1182/blood.v104.11.5015.5015
https://doi.org/10.1182/blood.v104.11.5015.5015
Autor:
Julio C. Rojas-Martinez, Luis Villela, Irene Anaya, Maria de la Luz Mendizabal, Rosa E. De Leon, José DeDiego, Leonel Ochoa, Jorge Duque, Roberto Hernandez, Guadalupe Gonzalez, Martha Alvarado, Severiano Baltazar, Jose R. Borbolla Escoboza, Eduardo Romero, Teresa Pompa, Jorge L. Juarez, Rosa María Romero Jiménez, Jason A. Penniecook, Enrique Baez, Marcos Garza-Madrid, Monica Tejeda, Maria I. Leon-Castanon, Yara E. Tovar, Carlos Gil-Rondero, Manuel López-Hernández, Elvira Trueba, Cecilia Ramirez-Assad, Jorge Cruz-Rico, Mauricio González-Avante, Dolores Mejia, Gerardo Villarreal
Publikováno v:
Blood. 104:4312-4312
Although there have been extraordinary advances in leukemia therapy, there is still a large subset of cases in which complete remission or prolonged leukemia-free survival cannot be achieved. Some of this variability in results is thought to be relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ceee7b3ad52118e6f1ed341f6f9ec46
https://doi.org/10.1182/blood.v104.11.4312.4312
https://doi.org/10.1182/blood.v104.11.4312.4312